Published in Kardiol Pol on January 01, 2011
[Comment to article Polscy lekarze nie są mistrzami w terapii cukrzycy]. Kardiol Pol (2011) 0.75
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med (2009) 5.34
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16
Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med (2013) 4.37
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54
The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med (2010) 3.47
Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med (2012) 3.39
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med (2014) 3.37
GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30
Validity of composite end points in clinical trials. BMJ (2005) 3.26
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab (2003) 3.25
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ (2007) 3.06
A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med (2003) 3.06
GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02
Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91
GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83
Users' guide to detecting misleading claims in clinical research reports. BMJ (2004) 2.55
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD (2005) 2.12
Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation (2006) 2.00
Incorporating considerations of resources use into grading recommendations. BMJ (2008) 1.94
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2007) 1.92
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90
Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol (2003) 1.75
Targeted temperature management in critical care: a report and recommendations from five professional societies. Crit Care Med (2011) 1.72
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol (2008) 1.57
Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. Int J Cardiol (2006) 1.53
Clinical predictors and hemodynamic consequences of elevated peripheral chemosensitivity in optimally treated men with chronic systolic heart failure. J Card Fail (2013) 1.52
Determinants of physical fitness in males with systolic heart failure. Kardiol Pol (2010) 1.45
[Outpatients specialist care of chronic obstructive pulmonary disease patients in Poland - results of the KOMPAS study]. Pneumonol Alergol Pol (2009) 1.43
Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J (2010) 1.42
What has changed in the treatment of ST-segment elevation myocardial infarction in Poland in 2003-2009? Data from the Polish Registry of Acute Coronary Syndromes (PL-ACS). Kardiol Pol (2011) 1.42
Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol (2013) 1.41
Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year. Kardiol Pol (2011) 1.39
Sexual dimorphism in socioeconomic differences regarding the risk factors, symptomatology and management of patients with stable coronary artery disease in Poland. Cardiol J (2015) 1.39
Analytical performance of glucometers used for routine glucose self-monitoring of diabetic patients. Clin Chim Acta (2003) 1.39
Association between carotid plaque score and microvascular complications of type 2 diabetes. Pol Arch Intern Med (2017) 1.39
Chronotropic response during exercise and recovery in men with mild systolic chronic heart failure. Kardiol Pol (2010) 1.37
Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care (2013) 1.36
A comparison of the original chronic respiratory questionnaire with a standardized version. Chest (2003) 1.31
GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol (2012) 1.30
Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J (2013) 1.29
Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.20
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.18
New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes (2006) 1.13
Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care (2013) 1.12
Lowering of glucose in critical care: a randomized pilot trial. J Crit Care (2007) 1.10
An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med (2009) 1.09
GRADE: assessing the quality of evidence for diagnostic recommendations. Evid Based Med (2008) 1.08
Comment on "Our prescription drugs kill us in large numbers". Pol Arch Med Wewn (2015) 1.07
Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links. Cardiovasc Res (2006) 1.04
Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail (2011) 1.03
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail (2010) 1.02
American Thoracic Society documents: an official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline--Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology (2012) 0.99
Iron status in patients with chronic heart failure. Eur Heart J (2012) 0.99
Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young. Diabetes Care (2008) 0.98
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary. Am J Health Syst Pharm (2013) 0.98
The 12-week progressive quadriceps resistance training improves muscle strength, exercise capacity and quality of life in patients with stable chronic heart failure. Int J Cardiol (2007) 0.97
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. PLoS One (2011) 0.97
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2013) 0.97
An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med (2011) 0.97
Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 0.96
Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes. Diabetes Res Clin Pract (2008) 0.96
Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity. Diabetes Care (2007) 0.96
Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Circulation (2006) 0.96
Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1alpha (MODY3) gene. Diabetes Care (2005) 0.96
Glycemic control in the ICU: a multicenter survey. Intensive Care Med (2004) 0.95
Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA (2009) 0.95
Development of porcine model of chronic tachycardia-induced cardiomyopathy. Int J Cardiol (2010) 0.94
GRADE: assessing the quality of evidence for diagnostic recommendations. ACP J Club (2008) 0.94
Consequences of peripheral chemoreflex inhibition with low-dose dopamine in humans. J Physiol (2014) 0.94
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.93
Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants. Eur J Heart Fail (2009) 0.93
Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones. J Cachexia Sarcopenia Muscle (2014) 0.92
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2013) 0.92
Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY. Rev Diabet Stud (2008) 0.92
Sleep disordered breathing in patients with heart failure. Cardiol J (2013) 0.92
Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol (2002) 0.91
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2009) 0.91
Hemicraniectomy for middle-cerebral-artery stroke. N Engl J Med (2014) 0.91
Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes. Diabetes Care (2007) 0.91
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. Int J Cardiol (2006) 0.90
Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther (2010) 0.90
Stress ulcer prophylaxis in critically ill patients: review of the evidence. Pol Arch Med Wewn (2012) 0.89
Tips for teachers of evidence-based medicine: understanding odds ratios and their relationship to risk ratios. J Gen Intern Med (2008) 0.89
Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis. Pol Arch Med Wewn (2008) 0.89
Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene. Diabetes Care (2007) 0.89
Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype. Clin Endocrinol (Oxf) (2008) 0.89
Dissociation between blood pressure and heart rate response to hypoxia after bilateral carotid body removal in men with systolic heart failure. Exp Physiol (2013) 0.88
The association of lower testosterone level with coronary artery disease in postmenopausal women. Int J Cardiol (2003) 0.88
[Glycemic index of meals and postprandial glycemia in patients with permanent neonatal diabetes due to Kir6.2 gene mutations]. Przegl Lek (2007) 0.87